10x Genomics, Inc.

BMV:TXG * Stock Report

Market Cap: Mex$35.5b

10x Genomics Management

Management criteria checks 3/4

10x Genomics' CEO is Serge Saxonov, appointed in Jul 2012, has a tenure of 12.33 years. total yearly compensation is $8.29M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 3.32% of the company’s shares, worth MX$1.18B. The average tenure of the management team and the board of directors is 2.8 years and 5.4 years respectively.

Key information

Serge Saxonov

Chief executive officer

US$8.3m

Total compensation

CEO salary percentage6.6%
CEO tenure12.3yrs
CEO ownership3.3%
Management average tenure2.8yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Serge Saxonov's remuneration changed compared to 10x Genomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$183m

Jun 30 2024n/an/a

-US$240m

Mar 31 2024n/an/a

-US$264m

Dec 31 2023US$8mUS$545k

-US$255m

Sep 30 2023n/an/a

-US$223m

Jun 30 2023n/an/a

-US$172m

Mar 31 2023n/an/a

-US$174m

Dec 31 2022US$19mUS$504k

-US$166m

Sep 30 2022n/an/a

-US$167m

Jun 30 2022n/an/a

-US$142m

Mar 31 2022n/an/a

-US$89m

Dec 31 2021US$12mUS$430k

-US$58m

Sep 30 2021n/an/a

-US$455m

Jun 30 2021n/an/a

-US$504m

Mar 31 2021n/an/a

-US$533m

Dec 31 2020US$11mUS$400k

-US$543m

Sep 30 2020n/an/a

-US$134m

Jun 30 2020n/an/a

-US$78m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$2mUS$394k

-US$31m

Sep 30 2019n/an/a

-US$100m

Jun 30 2019n/an/a

-US$105m

Mar 31 2019n/an/a

-US$105m

Dec 31 2018US$1mUS$366k

-US$112m

Compensation vs Market: Serge's total compensation ($USD8.29M) is above average for companies of similar size in the MX market ($USD699.19K).

Compensation vs Earnings: Serge's compensation has been consistent with company performance over the past year.

CEO

Serge Saxonov (47 yo)

12.3yrs

Tenure

US$8,286,050

Compensation

Dr. Serge Saxonov, Ph D, Co-Founded 10X Genomics, Inc. and has been its Chief Executive Officer and Director since July 2012. Prior to 10x Genomics, Dr. Saxonov was Vice President of Applications at Quanta...

Leadership Team

NamePositionTenureCompensationOwnership
Serge Saxonov
Co-Founder12.3yrsUS$8.29m3.32%
MX$ 1.2b
Benjamin Hindson
Co-Founder12.3yrsUS$4.43m2.68%
MX$ 949.1m
Eric Whitaker
Chief Legal Officer7.3yrsUS$3.88m0.12%
MX$ 41.5m
Adam Taich
CFO, Treasurerless than a yearno datano data
Jim Goodrich
Chief of Global Operationsless than a yearno datano data
Michael Schnall-Levin
Founding Scientist & CTO2.8yrsno datano data
Alexander Wong
Chief Information Officerless than a yearno datano data
Cassie Corneau
Manager of Investor Relations & Strategic Financeno datano datano data
Rebecca Port
Chief People Officer3.8yrsno datano data
Mennah Moustafa
Chief Commercial Officerless than a yearno datano data
Jens Durruthy
Associate Director of Product Managementno datano datano data

2.8yrs

Average Tenure

48.5yo

Average Age

Experienced Management: TXG *'s management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Serge Saxonov
Co-Founder12.3yrsUS$8.29m3.32%
MX$ 1.2b
Benjamin Hindson
Co-Founder12.3yrsUS$4.43m2.68%
MX$ 949.1m
Kimberly Popovits
Independent Director4.7yrsUS$338.71k0.0038%
MX$ 1.4m
John Stuelpnagel
Independent Chairman11.3yrsUS$403.59k2.02%
MX$ 715.5m
Shehnaaz Suliman
Independent Director5.3yrsUS$336.39k0.0038%
MX$ 1.4m
Alan Mateo
Directorless than a yearno datano data
Sridhar Kosaraju
Independent Director5.6yrsUS$346.39k0.029%
MX$ 10.4m
Sarah Polonius-Teichmann
Directorless than a yearno datano data

5.4yrs

Average Tenure

52yo

Average Age

Experienced Board: TXG *'s board of directors are considered experienced (5.4 years average tenure).